Aetna
Aetna Aetna
Specialty Pharmacy Clinical Policy Bulletins
Aetna Non-Medicare Prescription Drug Plan
Subject: Specialty Quantity Limit Cystaran-Cystadrops 2908-H P2023

Drug
CYSTARAN  (cysteamine ophthalmic solution)
CYSTADROPS  (cysteamine ophthalmic solution)


Policy:

      I.  PROGRAM DESCRIPTION

          The standard limit is designed to allow a quantity sufficient for
          the most common uses of the medication. The recommended
          dosing parameters for all FDA-approved indications fall within
          the standard limits. Coverage of an additional quantity may be
          reviewed on a case-by-case basis upon request.

   II.  COVERED QUANTITIES

  Medication

  Standard Limit

  FDA-recommended dosing

  Cystaran (cysteamine
  ophthalmic solution)
  0.44% 15mL bottle

  4 bottles
  per 28 days

  Instill one drop in each eye, every
  waking hour

         Discard after 1 week of use

  Cystadrops (cysteamine
  ophthalmic solution)
  0.37% 5mL solution
  (in 10mL bottle)

  4 bottles
  per 28 days

  Instill one drop in each eye, four times
  a day during waking hours

        Discard after 1 week of use

 


Place of Service:

Outpatient

The above policy is based on the following references:
  1. Cystaran [package insert]. Amityville, NY: Hi-Tech Pharmacal Co., Inc.; February 2022.
  2. Cystadrops [package insert]. Lebanon, NJ: Recordati Rare Diseases Inc.; August 2020.
Copyright Aetna Inc. All rights reserved. Pharmacy Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. This Clinical Policy Bulletin contains only a partial, general description of plan or program benefits and does not constitute a contract. Aetna does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Aetna or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. This Clinical Policy Bulletin may be updated and therefore is subject to change.

June 18, 2023
Aetna
Skip Past Footer Links
Company Information   |   Site Map Aetna.com Home   |   Help   |   Contact Us   |   Search
Web Privacy Statement   |   Legal Statement   |   Privacy Notices   |   Member Disclosure

Back to top